M. Scott

MARIMO cells harbor a CALR mutation but are not dependent on JAK2/STAT5 signaling

A. Green, H. Quentmeier, A. Bench, 2014, Leukemia.

Molecular genetic analysis of haematological malignancies II: mature lymphoid neoplasms

G. Follows, W. Erber, A. Bench, 2007, International journal of laboratory hematology.

The role of high-throughput technologies in clinical cancer genomics

James Hadfield, George S Vassiliou, J. Hadfield, 2013, Expert review of molecular diagnostics.

KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype

J. Martinez-Climent, N. Bolli, G. Gundem, 2014, Leukemia.

Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture

P. Ellis, A. Bradley, I. Varela, 2013, Leukemia.

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

P. Campbell, A. Green, G. Vassiliou, 2005, The Lancet.

MYELOID NEOPLASIA Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies

C. Tyler-Smith, Z. Ning, J. Chi, 2016 .

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

P. Campbell, A. Green, G. Vassiliou, 2005, The Lancet.